St. Antonius Hospital, Nieuwegein   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Nieuwegein Netherlands (1910)

Organization Overview

First Clinical Trial
2005
NCT00126698
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

dr. P. Noordzij | Human Adams | J.M. ten Berg | St Antonius center for platelet function research | St. Antonius Hospital | St Antonius Hospital, Department of Clinical Pharmacy | St Antonius Hospital, dept of anesthesiology | St Antonius Hospital, dept. of anesthesiology | ST. Antonius hospital Nieuwegein | St. Antonius Hospital Nieuwegein, Department of Cardiology | St. Antonius Hospital Nieuwegein, the Netherlands | St Antoniusziekenhuis | St. Antoniusziekenhuis | St. Antonius ziekenhuis | St. Antonius Ziekenhuis | St. Antonius Ziekenhuis Nieuwegein | St. Antonius Ziekenhuis Nieuwegein, The Netherlands | St. Antonius Ziekenhuis, Nieuwegein, The Netherlands

Active Ingredients

Drugs in Phase 4 Trials (28)

acetaminophen (tylenol) (1 trial)

acetylsalicylic acid (aspirin) (2 trials)

atorvastatin (lipitor) (1 trial)

atracurium (tracurium) (1 trial)

ciprofloxacin (cipro) (1 trial)

clopidogrel (plavix) (4 trials)

dabigatran (pradaxa) (1 trial)

doxazosin (cardura) (1 trial)

fentanyl (Innovar) (1 trial)

ferric derisomaltose (1 trial)

fibrinogen (human) (RiaSTAP) (1 trial)

fluconazole (diflucan) (1 trial)

methotrexate (1 trial)

micafungin (mycamine) (1 trial)

midazolam (versed) (2 trials)

natalizumab (tysabri) (1 trial)

phenoxybenzamine hydrochloride (dibenzyline) (1 trial)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)

posaconazole (noxafil) (1 trial)

prasugrel (effient) (1 trial)

prednisolone (hydeltra) (1 trial)

propofol (diprivan) (2 trials)

remifentanil (ultiva) (1 trial)

sodium chloride (1 trial)

sulfamethoxazole (gantanol) (1 trial)

ticagrelor (brilinta) (2 trials)

trimethoprim (1 trial)

urea (4 trials)

Drugs in Phase 3 Trials (14)

articaine (Septocaine) (1 trial)

docetaxel (taxotere) (1 trial)

ecologic (1 trial)

enoxaparin (lovenox) (1 trial)

heparin (liquaemin) (1 trial)

lidocaine (xylocaine) (1 trial)

octreotide (sandostatin) (2 trials)

oxaliplatin (eloxatin) (1 trial)

platelet rich plasma (1 trial)

rituximab (rituxan) (1 trial)

sitagliptin (januvia) (1 trial)

sugammadex (bridion) (1 trial)

voriconazole (vfend) (1 trial)

zr89-rituximab (1 trial)

Drugs in Phase 2 Trials (1)

ruc-4 (1 trial)

Drugs in Other Trials (14)

clarithromycin (biaxin) (1 trial)

gabapentin (neurontin) (1 trial)

gentamicin (garamycin) (1 trial)

inactivated influenza vaccine (2 trials)

levetiracetam (keppra) (1 trial)

levobupivacaine (chirocaine) (1 trial)

lorazepam (ativan) (1 trial)

morphine (1 trial)

phenytoin (mesantoin) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

ropivacaine (naropin) (1 trial)

sufentanil (1 trial)

thiopental (pentothal) (1 trial)

valproic acid (depakene) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Anemia (Phase 3)

Aneurysm (Phase 4)

Angina, Stable (Phase 3)

Angina, Unstable (Phase 4)

Angiodysplasia (Phase 3)

Aortic Aneurysm, Thoracic (Phase 4)

Aortic Valve Stenosis (Phase 4)

Bacteriuria (Phase 4)

Candidiasis (Phase 4)

Carcinoma (Phase 3)

Chest Pain (Phase 4)

Chronic Pain (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 2)

Dermatitis (Phase 3)

Dermatitis, Atopic (Phase 3)

Eczema (Phase 3)

Embolism (Phase 4)

Embolism and Thrombosis (Phase 4)

Gastrointestinal Hemorrhage (Phase 3)

Heart Diseases (Phase 2)

Hemorrhage (Phase 4)

Infarction (Phase 4)

Insulin Resistance (Phase 3)

Invasive Fungal Infections (Phase 4)

Lung Diseases (Phase 3)

Lung Diseases, Interstitial (Phase 3)

Multiple Sclerosis (Phase 4)

Mycoses (Phase 4)

Myocardial Infarction (Phase 4)

Neoplasms (Phase 3)

Non-ST Elevated Myocardial Infarction (Phase 4)

Obesity (Phase 4)

Obesity, Morbid (Phase 4)

Peritoneal Neoplasms (Phase 3)

Pheochromocytoma (Phase 4)

Pneumonia (Phase 4)

Reperfusion Injury (Phase 4)

Respiratory Insufficiency (Phase 3)

Rupture (Phase 3)

Sarcoidosis (Phase 4)

Sarcoidosis, Pulmonary (Phase 4)

Sclerosis (Phase 4)

Shoulder Impingement Syndrome (Phase 3)

ST Elevation Myocardial Infarction (Phase 2)

Stomach Neoplasms (Phase 3)

Syndrome (Phase 4)

Telangiectasia, Hereditary Hemorrhagic (Phase 2)

Telangiectasis (Phase 2)

Thrombosis (Phase 4)

Urinary Tract Infections (Phase 4)

Vascular Diseases (Phase 2)

Vascular Malformations (Phase 3)

Ventricular Remodeling (Phase 4)

Weight Loss (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 45
  • # of Trial APIs: 57